
IDEAYA Biosciences Investor Relations Material
Latest events

R&D Day 2024
IDEAYA Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IDEAYA Biosciences Inc
Access all reports
IDEAYA Biosciences Inc. is a clinical-stage biotechnology firm primarily engaged in the discovery and development of precision medicine therapeutics for cancer patients. The company's research focuses on synthetic lethality, an innovative class of precision medicine targets, aiming to produce therapeutics that are first-in-class and/or best-in-class. IDEAYA Biosciences leverages molecular diagnostics to select patient populations for its targeted therapies, emphasizing an integrated approach to the discovery and development of biomarkers and therapeutics. This approach spans early discovery through clinical development, targeting unmet needs in cancer treatment. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for IDEAYA Biosciences Inc


R&D Day 2024
IDEAYA Biosciences Inc


Study Update
IDEAYA Biosciences Inc
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
IDYA
Country
🇺🇸 United States